Cosmax BTI, Inc. Stock

Equities

A044820

KR7044820009

Food Processing

End-of-day quote Korea S.E. 18:00:00 2024-05-20 EDT 5-day change 1st Jan Change
10,120 KRW +2.02% Intraday chart for Cosmax BTI, Inc. -0.49% -4.80%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2,217B 1.63B 2.22B Sales 2025 * 2,501B 1.84B 2.5B Capitalization 96.69B 70.97M 96.79M
Net income 2024 * 123B 90.28M 123M Net income 2025 * 150B 110M 150M EV / Sales 2024 * 0.27 x
Net Debt 2024 * 503B 369M 504M Net Debt 2025 * 441B 324M 441M EV / Sales 2025 * 0.21 x
P/E ratio 2024 *
0.93 x
P/E ratio 2025 *
0.77 x
Employees -
Yield 2024 *
4.94%
Yield 2025 *
4.94%
Free-Float 38.55%
More Fundamentals * Assessed data
Dynamic Chart
Cosmax BTI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cosmax BTI, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cosmax BTI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Cosmax BTI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Lee, Byung Man acquired a 5.471515% stake in Cosmax BTI, Inc. from Recipe Co., Ltd. for KRW 4.4 billion. CI
Cosmax BTI, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Cosmax BTI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Cosmax Bti, Inc. Discovers "2Nd Generation Skin Microbiome". the Pioneering Continues CI
Cosmax BTI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Cosmax BTI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Cosmax BTI, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Cosmax BTI, Inc. announced that it has received KRW 15 billion in funding from Mirae Asset Securities Co., Ltd., Shinhan Investment Corp., Kiwoom Securities Co., Ltd., BNK Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
Cosmax BTI, Inc. announced that it expects to receive KRW 15 billion in funding from Mirae Asset Securities Co., Ltd., Shinhan Investment Corp., Kiwoom Securities Co., Ltd., BNK Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. and other investors CI
COSMAX Launches True Sensitive-skin Friendly Cosmetics CI
Cosmax BTI, Inc.’s Equity Buyback announced on January 2, 2020, has expired. CI
More news
1 day+2.02%
1 week-0.49%
Current month+5.42%
1 month+7.32%
3 months+1.00%
6 months-2.69%
Current year-4.80%
More quotes
1 week
9 840.00
Extreme 9840
10 130.00
1 month
9 220.00
Extreme 9220
10 240.00
Current year
9 170.00
Extreme 9170
10 620.00
1 year
8 500.00
Extreme 8500
11 490.00
3 years
7 150.00
Extreme 7150
21 550.00
5 years
7 150.00
Extreme 7150
26 850.00
10 years
7 150.00
Extreme 7150
109 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 78 15-03-19
Director of Finance/CFO 53 15-12-31
Chairman 71 -
Members of the board TitleAgeSince
Chief Executive Officer 78 15-03-19
Chairman 71 -
Director/Board Member 70 -
More insiders
Date Price Change Volume
24-05-21 10,120 +2.02% 9,719
24-05-20 9,920 -0.70% 6,987
24-05-17 9,990 -0.10% 3,915
24-05-16 10,000 -1.67% 16,811
24-05-14 10,170 +1.19% 11,945

End-of-day quote Korea S.E., May 20, 2024

More quotes
COSMAXBTI, INC. is a Korea-based company mainly engaged in manufacturing cosmetics. Through its subsidiaries in China, Indonesia and the United Sates, the Company operates its business through three segments: cosmetics segment, which produces cosmetics such as skin care, make-up, hair care and functional cosmetics; healthy food segment, which produces vitamins and diet drugs, and other segment, which produces cosmetics and plastic pumps. The Company distributes its products within domestic market and to overseas markets.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10,120 KRW
Average target price
180,000 KRW
Spread / Average Target
+1,678.66%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A044820 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW